Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2013
05/30/2013WO2013076680A1 Strategy for the assay of enzyme and enzyme mixtures for the hydrolysis lignocellulosic biomass
05/30/2013WO2013076444A1 Methods for detecting of benign conditions
05/30/2013WO2013076282A1 A method for predicting responsiveness to a treatment with an egfr inhibitor
05/30/2013WO2013076157A1 Marker for blood coagulation
05/30/2013WO2013076143A1 Detecting analytes
05/30/2013WO2013076029A1 Responsiveness to angiogenesis inhibitors
05/30/2013WO2013075629A1 Method for detecting hydroxylmethylation modification in nucleic acid and use thereof
05/30/2013WO2013075608A1 Chimeric recombinant antigen and use thereof
05/30/2013WO2013075313A1 Probe for detecting method of integration of virus in test sample and preparation method and use thereof
05/30/2013WO2013075285A1 One-class bi-benzyl pentamethyl cyanine fluorescent dye, and preparation method and application thereof
05/30/2013WO2013075263A1 Device for thermal convection polymerase chain reaction
05/30/2013WO2013075237A1 Mutations of histone proteins associated with proliferative disorders
05/30/2013WO2013075222A1 Populations of hematopoietic progenitors and methods of enriching stem cells therefor
05/30/2013WO2013049398A3 Protein-protein interaction as biomarkers
05/30/2013WO2013038010A3 Nucleic acid transcription method
05/30/2013WO2013020714A3 Cell- or virus simulating means comprising encapsulated marker molecules
05/30/2013WO2013009143A3 Marker for diagnosing diabetic retinopathy
05/30/2013WO2012174378A3 Methods and materials for assessing allelic imbalance
05/30/2013WO2012078053A8 Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder
05/30/2013WO2011123246A3 Solid-phase clonal amplification and related methods
05/30/2013US20130139277 Agricultural business applications and methods of use
05/30/2013US20130137835 Preparation of Polyphosphazene Microspheres
05/30/2013US20130137763 Fused cyclooctyne compounds and their use in metal-free click reactions
05/30/2013US20130137753 Methods and compositions for the diagnosis and treatment of breast cancer
05/30/2013US20130137751 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
05/30/2013US20130137748 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
05/30/2013US20130137669 Macrocyclic lactone resistance marker for dirofilaria immitis
05/30/2013US20130137627 Methods and kits for identifying a premature infant at risk of having or developing bronchopulmonary dysplasia
05/30/2013US20130137604 Methods of evaluating genetic elements
05/30/2013US20130137603 Newly identified colon cancer marker and diagnostic kit using the same
05/30/2013US20130137602 Arbitrary assembly of nano-objects into designed 1d and 2d arrays
05/30/2013US20130137599 Lipid multilayer microarrays and their use for cell culture screening
05/30/2013US20130137597 Microrna-based method for anti-colorectal cancer effects and prognosis of colorectal cancer
05/30/2013US20130137596 MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors
05/30/2013US20130137594 Systems and methods for performing amplicon rescue multiplex polymerase chain reaction (pcr)
05/30/2013US20130137593 Early detection and staging of colorectal cancer using a panel of micro rnas
05/30/2013US20130137590 Assessment of Oocyte Competence
05/30/2013US20130137589 Analysis of y-chromosome str markers
05/30/2013US20130137588 Sequence tag directed subassembly of short sequencing reads into long sequencing reads
05/30/2013US20130137587 Combinatorial sequence barcodes for high throughput screening
05/30/2013US20130137586 Stabilization of nucleic acids in cell material-containing biological samples
05/30/2013US20130137585 New combination of eight risk alleles associated with autism
05/30/2013US20130137584 Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies
05/30/2013US20130137583 Complexity Management of Genomic DNA
05/30/2013US20130137166 System and method including analytical units
05/30/2013US20130137164 System and method including analytical units
05/30/2013US20130137146 Methods for nucleic acid manipulation
05/30/2013US20130137145 Methods for nucleic acid manipulation
05/30/2013US20130137134 Method and system for detecting and monitoring hematological cancer
05/30/2013US20130137133 Ultrasonic dissection device and ultrasonic dissection method
05/30/2013US20130137132 Cardiomyocyte containing device, manufacturing method and measuring method
05/30/2013US20130137126 Use of a beta-glucosidase activator for the detection and/or identification of c. difficile
05/30/2013US20130137125 Crystal structure of human jak3 kinase domain complex and binding pockets thereof
05/30/2013US20130137118 Integrin heterodimer and a subunit thereof
05/30/2013US20130137116 Method and kit for detecting the early onset of renal tubular cell injury
05/30/2013US20130137111 Detection method of novel ret fusion
05/30/2013US20130137110 System and method including analytical units
05/30/2013US20130137109 System and method including analytical units
05/30/2013US20130137108 Magnetic bead separation apparatus and method
05/30/2013US20130137107 Rapid nucleic acid purification
05/30/2013US20130137106 Tumor Marker and Methods of Use Thereof
05/30/2013US20130137103 Analysis
05/30/2013US20130137102 Methods and kits for modulating tumor invasiveness and metastatic potential
05/30/2013US20130137101 Methods of Modifying Eukaryotic Cells
05/30/2013US20130137099 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms
05/30/2013US20130137098 Method of dna sequencing by hybridisation
05/30/2013US20130137097 High throughput single nucleotide polymorphism assay
05/30/2013US20130137096 Diagnosis of Hereditary Spastic Paraplegias (HSP) by Identification of a Mutation in the ZFVYE26 Gene or Protein
05/30/2013US20130137095 Method for identifying target base sequence
05/30/2013US20130137090 Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement
05/30/2013US20130137089 Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
05/30/2013US20130137087 System and method including analytical units
05/30/2013US20130137086 HPV DNA Methylation Patterns of Diagnostic or Prognostic Significance in Cervical Cancer Screening
05/30/2013US20130137084 Single Nucleotide Polymorphism on Chromosome 15 That Predicts HCV Treatment Responses
05/30/2013US20130136799 Monitoring health and disease status using clonotype profiles
05/30/2013US20130136786 Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent
05/30/2013US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments
05/30/2013US20130136755 Mlk4 gene, a new diagnostic and prognostic marker in cancers
05/30/2013US20130136726 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions
05/30/2013US20130136720 Methods of using fut2 genetic variants to diagnose crohn's disease
05/30/2013US20130136694 Method for identifying cancer drug candidates in drosophila
05/30/2013CA2856881A1 Versatile and sensitive biosensor
05/30/2013CA2856867A1 Methods for producing retinal tissue and retina-related cell
05/30/2013CA2856594A1 A method for predicting responsiveness to a treatment with an egfr inhibitor
05/30/2013CA2856382A1 Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
05/30/2013CA2856345A1 Device for thermal convection polymerase chain reaction
05/30/2013CA2856322A1 Populations of hematopoietic progenitors and methods of enriching stem cells therefor
05/30/2013CA2856252A1 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non-response alleles
05/30/2013CA2856137A1 Virus vectors for highly efficient transgene delivery
05/30/2013CA2855139A1 Fibrinogen assay
05/30/2013CA2854921A1 Methods of treatment using an antibody against interferon gamma
05/30/2013CA2854568A1 Responsiveness to angiogenesis inhibitors
05/30/2013CA2854255A1 Mutations of histone proteins associated with proliferative disorders
05/30/2013CA2853136A1 Methods of diagnosing and treating idiopathic pulmonary fibrosis
05/29/2013EP2597468A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3
05/29/2013EP2597163A1 The large form of human 2',5'-oligoadenylate synthetase OAS3 for preventing or treating infection with positive-sense single-stranded RNA viruses
05/29/2013EP2597162A1 Nucleic acid detection
05/29/2013EP2597161A2 Method of manufacturing micro chamber plate with built-in sample and analytic micro chamber plate, analytic micro chamber plate and apparatus set for manufacturing analytic micro chamber plate with built-in sample
05/29/2013EP2597160A1 Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter
05/29/2013EP2597159A1 Method for identifying cows with mastitis by bulk genotyping of tank milk
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 3003